ARTICLE
10 January 2020

J A Kemp Appoints Biotechnology And Life Sciences Partner

JA
J A Kemp LLP

Contributor

J A Kemp is a leading firm of European Patent and Trade Mark Attorneys. We combine independent thinking with collective excellence in all that we do. The technical and legal knowledge that we apply to the protection of our clients’ patents is outstanding in its breadth and depth. With around 100 science and technology graduates in the firm, including 50 PhDs, no area of science or technology is outside our scope. Our Patent Attorneys have collective in-depth expertise in patent law and procedure in every country of the world. The team of professionals who advise our clients on trade mark and design matters have backgrounds in major international law firms and hold qualifications as Chartered UK Trade Mark Attorneys, Solicitors and European Trade Mark Professional Representatives. Dedicated to this specialist area of intellectual property protection, the team has the expertise and resources to protect trade marks and designs in any market worldwide.
Ian is qualified as a European and UK Chartered Patent Attorney. He joined J A Kemp in January 2020 after working for over ten years at another top tier firm.
United Kingdom Food, Drugs, Healthcare, Life Sciences
Ian MacLeod’s articles from J A Kemp LLP are most popular:
  • with Senior Company Executives and HR
  • in European Union
  • in European Union
  • in European Union
  • in European Union
  • in European Union
  • with readers working within the Law Firm industries

J A Kemp LLP has appointed Dr Ian MacLeod as a Partner in its London office.

Ian is qualified as a European and UK Chartered Patent Attorney. He joined J A Kemp in January 2020 after working for over ten years at another top tier firm.

Ian handles a wide range of subject matter in the biotechnological and life sciences field, with particular expertise in bacterial products targeting the microbiome, vaccines, antibody therapeutics, biomarker diagnostics, and antisense nucleotides.

Ian has extensive experience of drafting patents and of prosecuting and defending global patent portfolios. Having helped his clients obtain the grant of commercially important patents, he frequently defends them at the European Patent Office, including in multi-party cases up to the Boards of Appeal. He is also experienced in handling multi-jurisdiction litigation actions across Europe and around the world. In addition, Ian advises on complex freedom to operate and infringement matters and assists with licence negotiations.

Before joining the profession, Ian studied Natural Sciences at Cambridge University, specialising in Genetics, and undertook a PhD at the Cambridge Institute for Medical Research. His PhD research characterised the toxic polymerisation of mutant neuroserpin, which causes a rare dementia, through the development and utilisation of a Drosophila model of the disease.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More